Delivery Order SPE2DB20D7066-SPE2DB25FC3QY
Award Date
6/10/25
Potential Completion Date
6/11/25
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $1,148.88 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of June 6, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside for any specific business type....
This contract award is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM medical supplies to the Defense Logistics Agency (DLA). The $1,527.47 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a period of performance through March 24, 2025. No set-aside was used for this award. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM medication. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has a firm fixed price ceiling value of $2,090.40. The award is a delivery order with a period of performance through May 15, 2025. This contract is not set aside and represents open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,484.70 for the supply of budesonide-formoterol 160-4.5 10.2GM medication. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a period of performance through November 2024. The contract type is firm fixed price. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product, with an ultimate completion date of January 9, 2025 and a ceiling value of $1,556.92. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a specific set-aside...
This federal contract award, valued at $1,372.04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product, with a completion date of February 20, 2025. The contract is a Delivery Order under a Firm Fixed Price structure, and there was no set-aside designation used. AmerisourceBergen holds a significant...
This federal contract award is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $1,460.46, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The contract is a delivery order under...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of budesonide-formoterol 160-4.5 10.2GM, a type of pharmaceutical product, with a ceiling value of $28,650.68 and a completion date of March 7, 2025. The contract is a Delivery Order and has a Firm Fixed Price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $1,709.60 with a Firm Fixed Price pricing type. The award is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product. The contract has an ultimate completion date of March 27, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $14,295.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of Budesonide-Formoterol 80-4.5 10.2GM, a pharmaceutical product, with a performance period extending through May 8, 2025. The contract is a firm fixed-price, non-set-aside arrangement, indicating open competition. Amerisourcebergen Drug Corp...